Journal of Cardiac Failure

Papers
(The H4-Index of Journal of Cardiac Failure is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Outcomes Of Hospitalization In Patients With Diastolic Heart Failure Undergoing Hematopoietic Stem Cell Transplant (HSCT): A National Inpatient Sample Analysis (2002-2019)618
Electrolyte Variability During Acute Decompensated Heart Failure Hospitalization340
Efficacy And Safety Of Intravenous Iron In Patients With Iron Deficiency Anemia And Heart Failure With Reduced Ejection Fraction. A Systematic Review And Meta-analysis316
Weight Loss Management By A Pharmacist To Overcome Obesity As A Barrier To Surgical Advanced Heart Failure Interventions83
Proteomic Correlates Of Urinary Protein Creatinine Ratio In Heart Failure With Preserved Ejection Fraction79
Psoas Muscle Index As An Independent Risk Factor Predictive Of Increased Post Operative Length Of Stay In Orthotopic Heart Transplant Candidates78
Prognostic Value Of Percentage Of Predicted Peak Oxygen Consumption Using Functional Aerobic Impairment And Friend Equations In Patients With Heart Failure With Reduced Ejection Fraction70
Effect Of Mavacamten On Echocardiographic Parameters In Patients With Obstructive Hypertrophic Cardiomyopathy: A Real World Cohort64
Readmission Rate And Hospitalization Costs In HFpEF In Patients With OSA64
Methodological Quality Of Clinical Practice Guidelines In Heart Failure: A Systematic Critical Appraisal Using The Agree II Tool62
A Resident-led Initiative To Improve Heart Failure Readmission Rate By Targeting Factors Of Social Vulnerability59
Synchronized Diaphragmatic Stimulation As A Potential Outpatient Implant Procedure For HfrEF Therapy59
Heartfelt Advances: ACC 2024 Clinical Trials Spotlight—New Horizons in Heart Failure Management57
JCF Heart Failure Year-In-Review 2023… Shaping the Future of Heart Failure56
From Inflammation to Inspiration and Innovation: A New Perspective on the Utility of Anti-inflammatory Therapies for Acute Heart Failure55
Improving ATTR-CM Detection: Targeting Populations With the Greatest Need53
Higher ECMO Flow Index And Hyperoxia Are Associated With Increased Mortality In Adults With Cardiogenic Shock Receiving Venoarterial Extracorporeal Membrane Oxygenation: An ELSO Registry Analysis51
Development And Implementation Of An Rv Stress Test To Assess Rv Reserve Pre-lvad51
Masthead49
The Swan is not the Ugly Duckling47
COUNTERPOINT: Abandon or Reassess? Interpreting Treatment Effects in “Negative” Clinical Trials46
Younger Adults Have Discordant Heart Failure Symptoms44
Durable Mechanical Circulatory Support: The Spring of Hope or the Winter of Despair?44
PHOSPHOPROTEOMIC INSIGHTS INTO PATHOBIOLOGY AND POTENTIAL DRUG TARGETS IN A PORCINE MODEL OF EXPERIMENTALLY INDUCED PULMONARY VENOUS HYPERTENSION43
QT Interval Correction In Left Bundle Branch Areas Pacing (LBBAP)43
Cardiovascular Interplay Between Heart Failure Patients With Concurrent Depression, A Comprehensive Retrospective Analysis43
Ventricular Assisted Device In Transposition Of Great Arteries: Indications, Outcomes, Hemodynamic Insights42
Outcomes In Patients With Right Ventricular Failure & Preserved Left Ventricular Systolic Function On Short-term Inotropic Support42
Association Of Amiodarone With Rvf Post Lvad41
Emerging Adults: a Group Caught in the Middle40
Cardiac Magnetic Resonance In Patients With Suspectedtachycardia-induced Cardiomyopathy - The Impact Of Lategadolinium Enhancement And Epicardial Fat Tissue40
Differences In Lung Fluid Quality Between Decompensated Heart Failure Patients And Covid-19 Patients- Results Of The Impedance-corona Trial39
Hospitalization For Acute Kidney Injury In Patients With Heart Failure & Atrial Fibrillation Is Associated With Greater Risk Of Cardiogenic Shock & Major Adverse Cardiovascular Outcomes38
No Competition, No Progress36
A Distinction Between Wellness and Resilience36
Symptomatic Heart Failure With Preserved Ejection Fraction: Is It Too Late to Consider Additional Therapies?36
0.14148211479187